Rabbits with experimentally induced pneumococcal meningitis were given single 25-mg/kg doses of apalcillin or cefpiramide. Mean percentages of the drug concentration in cerebrospinal fluid versus that in blood serum were 7.6% with apalcillin and 3.9% with cefpiramide. Bactericidal activity in cerebrospinal fluid resulted in mean reductions of from 4 to 5 loglo CFU/ml, and cerebrospinal fluid cultures became sterile for four of six animals treated with each drug.
Apalcillin, a naphthyridine-carboxamido derivative of ampicillin, and cefpiramide, a semisynthetic cephalosporin, have in vitro spectra of activity that are very similar to those of mezlocillin and piperacillin (1, 4, 5) . As such, these new drugs fall into the family of broad-spectrum anti-Pseudomonas beta-lactam antibiotics. The spectrum includes the pathogens that most commonly cause meningitis. We evaluated apalcillin and cefpiramide in the rabbit model for experimental bacterial meningitis (2).
To produce meningitis, 3.1 x 105 (range, 5 x 104 to 1.3 x 106) CFU of a strain of Streptococcus pneumoniae type 6 was injected intracisternally into 2-to 3-kg New Zealand white male rabbits. The challenge strain had originally been isolated from the cerebrospinal fluid (CSF) of a child with meningitis and has been used in our previous studies (2) . By broth dilution testing, the strain was inhibited in vitro by less than 0.03 ,ug of both drugs per ml, and the MBCs of both drugs were 0.06 jig/ml. At Table 1 . Peak antibiotic concentrations in serum were ca. 50%o greater with cefpiramide than with apalcillin, but because of the faster rate of clearance of cefpiramide, cefpiramide concentrations after 6 h and the areas under the concentration timecurve were smaller than those measured for apalcillin.
Apalcillin exhibited approximately twice the degree of penetration into CSF as that of cefpiramide ( Table 1 ). The larger concentrations of apalcillin in CSF resulted in greater bactericidal activity because the MBCs in vitro of both drugs were identical (Table 2 ). Bactericidal activity between 1:4 and 1:512 was present in all CSF samples after drug administration. The rates of elimination of bacteria from CSF over the 6-h period were similar with the two drugs, and four of six animals in each group had sterile CSF cultures at the end of the study period. With each drug the mean concentrations of bacteria in CSF were reduced by more than 104 CFU/ml compared with those found in control animals.
In our previous study (2) with this animal model of pneumococcal meningitis, penicillin G achieved 1.9% pene- 
